INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2013
|
Total net assets |
£154.8m |
|
NAV per share |
280.6p |
|
Share price |
248.0p |
|
Total value of unquoted investments |
£25.2m |
|
Total number of portfolio companies |
70 |
|
Cash |
3% NAV |
|
Cash committed and reserved to unquoted investments |
(5)% NAV |
|
Portfolio companies with < 1 year of cash |
13.26% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Gilead Celgene |
7.0 6.2 6.0 |
|
Onyx |
4.8 |
|
Aptiv |
3.7 |
|
Alexion |
3.6 |
|
Celldex |
3.4 |
|
Insulet |
2.9 |
|
Cepheid |
2.4 |
|
Biomarin |
2.3 |
|
|
----------- |
|
Total |
42.3 |
|
Geographical Allocation |
% |
|
United States & Canada |
88 |
|
Europe |
9 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
81 |
|
Unquoted |
16 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 MAY 2013